TY  - BOOK
AU  - Miguel Salavert et al
TI  - Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spainq
KW  - Computer science, information & general works
UR  - https://new.zodml.org/sites/default/files/2023-07/cost-effectiveness_analysis_of_bezlotoxumab_added_to_standard_of_care_versus_standard_of_care_alone_for_the_prevention_of_recurrent_clostridium_difficile_infection_in_high-risk_patients_in_spain.pdf
ER  -